A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial

NCT05946564 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

126

Enrollment

OTHER

Sponsor class

Conditions

ANCA Associated Vasculitis
Rapidly Progressive Glomerulonephritis
Crescentic Glomerulonephritis

Interventions

DRUG: Pioglitazone (ACTOS®)
DRUG: Placebo of Pioglitazone

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]